Founder/President, Physician Services Division and Chief Innovation Officer
Cota/Hackensack Meridian Health
Andrew L Pecora MD serves as President, Physician Services Division and Chief Innovation Officer of Hackensack Meridian Health in New Jersey, and Professor of Medicine Georgetown University. Dr. Pecora is leading efforts in value based payment reform and has served on several federal panels examining new models. He has developed and applied novel bundled cancer programs in collaboration with Horizon Blue Cross Blue Shield of NJ and has guided his cancer program in participation within the federal Oncology Care Model project. Dr. Pecora is also Division Chief of Skin and Sarcoma at the John Theurer Cancer Center at Hackensack University Medical Center and a member of the Regional Cancer Care Associates (previous chairman). Dr. Pecora is recognized internationally as one of the world’s foremost experts in blood and marrow stem cell transplantation, cellular medicine and immunology research. In 1989, he spearheaded the development of John Theurer Cancer Center’s Adult Blood and Marrow Stem Cell Transplantation Program and is responsible for many advancements used in stem cell transplantation today. Dr. Pecora’s current research involves developing vaccines and other cellular medicine techniques that boost the capabilities of a patient’s own immune system to fight cancer and targeted therapies that destroy cancer cells. His research has been published extensively in prestigious medical journals and he is a frequently requested lecturer at conferences all over the world. Dr. Pecora’s award-winning research is funded by the National Cancer Institute, Amgen, Merck and the AHEPA Research Foundation. He obtained his medical degree at the University of Medicine and Dentistry of New Jersey, with an internal medicine residence at The New York Hospital and a fellowship in hematology and oncology at Memorial Sloan-Kettering Cancer Center. He also is a Certified Physician Executive from the American College of Physician Executives.